Squarepoint Ops LLC Takes Position in ICU Medical, Inc. $ICUI

by · The Markets Daily

Squarepoint Ops LLC bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) in the second quarter, HoldingsChannel.com reports. The firm bought 25,540 shares of the medical instruments supplier’s stock, valued at approximately $3,744,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of ICUI. California State Teachers Retirement System increased its holdings in ICU Medical by 14,236.6% during the 2nd quarter. California State Teachers Retirement System now owns 3,944,273 shares of the medical instruments supplier’s stock worth $578,230,000 after purchasing an additional 3,916,761 shares during the period. BlackRock Inc. purchased a new position in shares of ICU Medical in the 2nd quarter valued at about $550,250,000. Jupiter Topco LLC acquired a new position in shares of ICU Medical during the second quarter worth about $407,786,000. Janus Henderson Group PLC grew its position in shares of ICU Medical by 3.9% during the first quarter. Janus Henderson Group PLC now owns 2,676,012 shares of the medical instruments supplier’s stock worth $345,607,000 after buying an additional 99,256 shares in the last quarter. Finally, Millennium Management LLC increased its stake in shares of ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after buying an additional 690,694 shares during the period. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. KeyCorp raised their target price on shares of ICU Medical from $164.00 to $182.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Zacks Research downgraded shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Wall Street Zen upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Piper Sandler lifted their price objective on shares of ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Finally, Raymond James Financial reiterated a “strong-buy” rating and set a $200.00 target price on shares of ICU Medical in a research note on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $192.80.

View Our Latest Research Report on ICUI

Insider Buying and Selling at ICU Medical

In related news, COO Christian Voigtlander sold 8,929 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total value of $1,633,381.97. Following the transaction, the chief operating officer directly owned 37,377 shares of the company’s stock, valued at $6,837,374.61. This trade represents a 19.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Elisha W. Finney sold 378 shares of ICU Medical stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $182.48, for a total transaction of $68,977.44. Following the sale, the director owned 4,871 shares in the company, valued at $888,860.08. This represents a 7.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 21,830 shares of company stock worth $3,905,003. 2.10% of the stock is owned by insiders.

ICU Medical Price Performance

Shares of NASDAQ ICUI opened at $156.48 on Friday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.21 and a current ratio of 2.43. ICU Medical, Inc. has a fifty-two week low of $112.50 and a fifty-two week high of $192.85. The firm has a market capitalization of $3.91 billion, a PE ratio of 132.61, a price-to-earnings-growth ratio of 1.98 and a beta of 0.75. The stock’s 50-day simple moving average is $168.36 and its 200-day simple moving average is $145.22.

ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.46. The firm had revenue of $547.88 million during the quarter, compared to the consensus estimate of $533.44 million. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the company posted $2.10 earnings per share. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. As a group, equities research analysts forecast that ICU Medical, Inc. will post 7.19 EPS for the current fiscal year.

About ICU Medical

(Free Report)

ICU Medical, Inc develops, manufactures and sells medical devices used in infusion therapy, critical care and oncology. Its product portfolio includes infusion pumps, IV administration sets, needle-free connectors, vascular access devices, patient monitoring equipment and related accessories designed to support the delivery of fluids and medications and the monitoring of patients in healthcare settings.

The company also provides products for the safe handling of hazardous drugs, including closed-system transfer devices used in oncology and pharmacy operations.

Featured Stories

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).